Ric Price is Professor of Global Health at the Menzies School of Health Research in Darwin Australia and Professor of Tropical Medicine at the Centre of Tropical Medicine, University of Oxford, UK. His translational research program focuses on improving the diagnosis and management of multidrug resistant P. falciparum and P. vivax infections. His work spans clinical drug trials, epidemiology, health economics, parasitology and molecular biology. He is head of the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and co-Chairs the Vivax Working Group of the Asia Pacific Malaria Elimination Network (APMEN).Related Projects
- Access and adherence to malaria interventions
- An external quality assurance program for PCR assays to quantify parasitaemia across laboratories in the Asia-Pacific region
- Developing better tools for diagnosing patients and populations at risk of primaquine induced haemolysis
- Developing new diagnostic tests for malaria
- Identifying “hot spots” and “hot pops” with serological surveillance and operational research of high sensitivity tests
- Identifying better treatments for uncomplicated malaria
- Identifying populations at risk of multidrug resistant malaria
- Molecular surveillance of malaria parasites to inform on local intervention strategies
- Understanding kinetics of antigens used in rapid diagnostic tests for malaria
- Within-host malaria modelling to improve the treatment of malaria
Related Publications
- A comparison of three methods to estimate G6PD activity in the Chittagong Hill Tracts, Bangladesh
- A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
- Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
- Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children
- An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax populations
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria: an open-label randomized controlled trial (CAN KNOW)
- Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
- Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax in Ethiopia: a randomized controlled trial
- Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination
- Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
- Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting
- Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
- Early and late mortality after malaria in young children in Papua, Indonesia
- Economic costs of vivax malaria episodes: A multi-country comparative analysis using primary trial data
- Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: an open-label randomised controlled trial
- Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
- Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis
- Genomic analysis of local variation and recent evolution in Plasmodium vivax
- Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite Mechanisms
- Genomic Analysis Reveals a Common Breakpoint in Amplifications of the Plasmodium vivax Multidrug Resistance 1 Locus in Thailand
- Genomic epidemiology of artemisinin resistant malaria
- Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
- Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
- Global extent of chloroquine-resistant Plasmodium vivax a systematic review and meta-analysis
- Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh
- Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh
- Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission
- Identifying and combating the impacts of COVID-19 on malaria
- Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia–Pacific region
- Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model.
- Imported malaria and its implication to achievement of malaria-free Bhutan
- Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
- Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
- Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling
- Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
- Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
- Major burden of severe anemia from non-falciparum malaria species in southern Papua: A hospital-based surveillance study
- Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs
- Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
- Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
- No Association between the Plasmodium vivax crt-o MS334 or In9pvcrt Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal Expansion
- Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria
- Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
- Plasmodium malariae and ovale genomes provide insights into malaria parasite evolution
- Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
- Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
- Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group
- Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas – a radomised controlled trial
- Relationship of circulating Plasmodium falciparum lifecycle stage to circulating parasitemia and total parasite biomass
- Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.
- Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
- Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
- Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
- Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
- Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
- The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools
- The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
- The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
- The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
- The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a pooled analysis of individual patient data
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
- The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
- The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
- Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection
- Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
- Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study
- Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis
- Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria